dexamethasone 21-palmitate has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T; Hara, T; Ihara, K; Ishii, K; Ishimura, M; Nagai, H; Ohga, S; Takada, H | 1 |
| Ohga, S; Wakiguchi, H | 1 |
1 review(s) available for dexamethasone 21-palmitate and Lung Diseases
| Article | Year |
|---|---|
Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation.
Topics: Animals; Arthritis; Dexamethasone; Disease Models, Animal; Graft vs Host Disease; Granuloma; Hemosiderosis; Humans; Hypothalamo-Hypophyseal System; Lung Diseases; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Macrophage Activation Syndrome; Pituitary-Adrenal System; Pulse Therapy, Drug; Rats | 2016 |
1 other study(ies) available for dexamethasone 21-palmitate and Lung Diseases
| Article | Year |
|---|---|
Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis.
Topics: Child; Child, Preschool; Dexamethasone; Drug Administration Schedule; Female; Glucocorticoids; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Infant; Infusions, Intravenous; Liposomes; Lung Diseases; Male; Microspheres; Retrospective Studies; Treatment Outcome | 2013 |